Company Filing History:
Years Active: 2021
Title: Richard Seeman: Innovator in Tissue Matrix Technologies
Introduction
Richard Seeman is a notable inventor based in South Bound Brook, NJ (US). He has made significant contributions to the field of tissue engineering and biomaterials. His innovative work focuses on enhancing the adhesion properties of tissue matrix products through enzymatic methods.
Latest Patents
Richard Seeman holds 1 patent for his invention titled "Tissue matrix materials and enzymatic adhesives." This patent relates to the use of transglutaminases to treat various tissue matrix products. The methods described in the patent include the application of a transglutaminase to a partially denatured collagen-containing tissue matrix, followed by the implantation of the tissue matrix. The transglutaminase facilitates adhesion with another collagen-containing tissue matrix or the surrounding tissue after implantation.
Career Highlights
Richard Seeman is currently associated with Lifecell Corporation, where he continues to advance his research in tissue matrix technologies. His work has the potential to improve surgical outcomes and enhance the healing process for patients.
Collaborations
Some of Richard's coworkers include Eric Stec and Ming F Pomerleau, who contribute to the innovative environment at Lifecell Corporation.
Conclusion
Richard Seeman's contributions to tissue engineering through his patented innovations demonstrate his commitment to advancing medical technology. His work is poised to make a lasting impact in the field of biomaterials and surgical applications.